Marshall Wace, LLP 10x Genomics, Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 46,861 shares of TXG stock, worth $559,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,861
Previous 467,123
89.97%
Holding current value
$559,520
Previous $10.5 Million
93.63%
% of portfolio
0.0%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding TXG
# of Institutions
293Shares Held
97.5MCall Options Held
255KPut Options Held
67.9K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$143 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$131 Million0.0% of portfolio
-
Morgan Stanley New York, NY6.48MShares$77.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$76.3 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$68.2 Million0.92% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.13B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...